Neuroone Medical Technologies (NMTC) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Neuroone Medical Technologies Corp  (NASDAQ: NMTC)

Neuroone Medical Technologies's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Neuroone Medical Technologies in the second quarter 2026?
Neuroone Medical Technologies Corp recorded a cumulative net loss of $-7 million during 12 months ending in the second quarter 2026, resulting in a negative return on equity (ROE) of -95.95%.

Within the Medical Equipment & Supplies industry 121 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2025 from 2340 to 3381.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2026)
II. Quarter		 (Dec 31 2025)
I. Quarter		 (Sep 30 2025)
IV. Quarter		 (Jun 30 2025)
III. Quarter		 (Mar 31 2025)
II. Quarter
Y / Y Equity Change 377.29 % 760.4 % 134.83 % 112.16 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -7 -7 -4 -5 -6
Return On Equity (TTM) -95.95 % -116.49 % -83.86 % -144.74 % -277.19 %
NMTC's Total Ranking # 3381 # 2340 # 3091 # 2879 # 3465
Equity (TTM) in Millions 5 7 7 8 1
Seq. Equity Change -24.02 % 0 % -13.51 % 626.33 % 36.97 %
Seq. Net Income Change - - - - -

Back to NMTC Management Effectiveness >> NMTC's 5 Years Annual ROE >> Compare NMTC ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 122
Sector # 537
Overall # 3381

Return On Equity Statistics
High Average Low
-74.68 %
-152.8 %
-277.69 %
(Sep 30 2025)   (Mar 31 2024)





NMTC Annual Return On Equity (Sep 30 2025)
2025		 (Sep 30 2023)
2023		 (Sep 30 2022)
2022		 (Sep 30 2021)
2021		 (Jul 31 2015)
2015
Total Equity in Millions 7 6 10 7 0
Y / Y Equity Change 13.17 % -34.93 % 46.54 % - -
Net Income in Millions -4 -12 -10 -10 0
Y / Y Net Income Change - - - - -
Return On Equity -50.98 % -189.77 % -104.12 % -151.79 % -

Back to NMTC Management Effectiveness >> NMTC's 5 Years Annual ROE >> Compare NMTC ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
NMTC's' Return on Equity at Yahoo Finance
NMTC's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for NMTC's Competitors
Subscribers only: Roe for Neuroone Medical Technologies's Suppliers
Subscribers only: Return On Equity for NMTC's Customers




Companies with similar Return On Equity at Mar 31 2026, within Healthcare Sector ROE

Date modified: 2026-09-18T10:53:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.